Kailera Therapeutics, Inc.
CIK: 0002096997
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 180 THIRD AVENUE, WALTHAM, MA, 02451
Mailing Address 180 THIRD AVENUE, WALTHAM, MA, 02451
Phone 508-440-9475
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | March 27, 2026 | View on SEC |
IPO Filings
S-1 March 27, 2026
- Targeting the high-growth obesity and metabolic disease market
- Lead candidate ribupatide currently in Phase 3 clinical trials
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.